Insider · CIK 0001805359
Christopher G. Hayes
Files at VRCA (Verrica Pharmaceuticals Inc.). First filing Mar 18, 2025, latest Mar 18, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VRCA: Verrica Pharmaceuticals Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | VRCAsell Verrica Pharmaceuticals Inc. | $2,805 4,315 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 17, 2025 | VRCA Verrica Pharmaceuticals Inc. | SOpen-market sale Common Stock | -4,315 | $0.65 | $2,805 | 176,458 | Mar 18, 2025 |
| Mar 14, 2025 | VRCA Verrica Pharmaceuticals Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +250,000 | $0.00 | $0 | 250,000 | Mar 18, 2025 |
| Oct 9, 2024 | VRCA Verrica Pharmaceuticals Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Oct 11, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.